Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: A prospective study

Journal of Critical Care

Volumn 29, Issue 3, 2014, Pages 327-333

  Johansson, Pär I ^a,b   Haase, Nicolai ^a   Perner, Anders ^a   Ostrowski, Sisse R ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Catecholamines; Coagulopathy; Endothelium; Sepsis; Sympathoadrenal activation

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; CATECHOLAMINE; CD40 LIGAND; NORADRENALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SYNDECAN 1; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN RECEPTOR 1; SYNDECAN; VASCULOTROPIN A;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD LEVEL; BLOOD SAMPLING; CELL DAMAGE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FIBRINOLYSIS; HEART INFARCTION; HUMAN; HYPOCOAGULABILITY; INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SEPSIS; THROMBOCYTE ACTIVATION; BLOOD; BLOOD CLOTTING; CONTROLLED STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SHOCK; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CATECHOLAMINES; CD40 LIGAND; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; SEPSIS; SHOCK; SYNDECANS; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84899904036     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.10.028     Document Type: Article

References (30)

1. Angus D.C., van der P.T. Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
2. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777.
3. Levi M., van der P.T., Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol 2011, 34. 10.1007/s00281-011-0283-7.
4. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
5. Dunser M.W., Hasibeder W.R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316.
6. Johansson P.I., Ostrowski S.R. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010, 75:564-567.
7. von Kanel R., Dimsdale J.E. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000, 65:357-369.
8. Makhmudov R.M., Mamedov Y., Dolgov V.V., et al. Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa 1985, 27:456-463.
9. Kristova V., Kriska M., Canova R., et al. Endothelial changes following repeated effect of vasoconstrictive substances in vitro. Acta Physiol Hung 1993, 81:363-370.
10. Hawkey C.M., Britton B.J., Wood W.G., et al. Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 1975, 29:377-384.
11. van der P.T., Levi M., Dentener M., et al. Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997, 185:1143-1148.
12. Sefrin P. Catecholamines in the serum of multiple trauma patients-mediators of ARDS?. Prog Clin Biol Res 1987, 236:477-486.
13. Johansson P.I., Stissing T., Bochsen L., et al. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45.
14. Ostrowski S.R., Sorensen A.M., Larsen C.F., et al. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med 2011, 19:64.
15. Johansson P.I., Stensballe J., Rasmussen L.S., et al. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 2012, 72:428-436.
16. Ostrowski S.R., Sørensen A.M., Windeløv N.A., et al. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation. Scand J Trauma Resusc Emerg Med 2012, 20:27.
17. Ostrowski S.R., Pedersen S.H., Jensen J.S., et al. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 2013, 17:R32.
18. Johansson P.I., Stensballe J., Rasmussen L.S., et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011, 254:194-200.
19. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013, 41:580-637.
20. Becker B.F., Chappell D., Bruegger D., et al. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87:300-310.
21. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134.
22. Schouten M., Wiersinga W.J., Levi M., et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83:536-545.
23. Brohi K., Cohen M.J., Ganter M.T., et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg 2007, 245:812-818.
24. Chernow B., Rainey T.G., Lake C.R. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982, 10:409-416.
25. Benedict C.R., Grahame-Smith D.G. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med 1978, 47:1-20.
26. van der P.T., Coyle S.M., Barbosa K., et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996, 97:713-719.
27. Levy B. Bench-to-bedside review: is there a place for epinephrine in septic shock?. Crit Care 2005, 9:561-565.
28. Benedict C.R., Rose J.A. Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992, 38:165-172.
29. de M.E., Aboab J., Mansart A., et al. Bench-to-bedside review: beta-adrenergic modulation in sepsis. Crit Care 2009, 13:230.
30. Novotny N.M., Lahm T., Markel T.A., et al. Beta-blockers in sepsis: reexamining the evidence. Shock 2009, 31:113-119.